000157224 001__ 157224
000157224 005__ 20240229123132.0
000157224 0247_ $$2doi$$a10.1016/j.jad.2020.07.044
000157224 0247_ $$2pmid$$apmid:32697695
000157224 0247_ $$2ISSN$$a0165-0327
000157224 0247_ $$2ISSN$$a1573-2517
000157224 0247_ $$2altmetric$$aaltmetric:86320019
000157224 037__ $$aDKFZ-2020-01494
000157224 041__ $$aeng
000157224 082__ $$a610
000157224 1001_ $$0P:(DE-He78)820d29ab03f702f61c6c92df377d2846$$aLiu, Zhunzhun$$b0$$eFirst author$$udkfz
000157224 245__ $$aThe relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: A systematic review.
000157224 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2020
000157224 3367_ $$2DRIVER$$aarticle
000157224 3367_ $$2DataCite$$aOutput Types/Journal article
000157224 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1603095558_20926$$xReview Article
000157224 3367_ $$2BibTeX$$aARTICLE
000157224 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157224 3367_ $$00$$2EndNote$$aJournal Article
000157224 500__ $$a#EA:C071#LA:C071#
000157224 520__ $$aStudies have reported mixed findings on the relationship between posttraumatic growth (PTG) and health-related quality of life (HRQOL) in cancer survivors. This review aims to give an overview of these studies and to identify potential study- and sample-level factors that could contribute to the heterogeneity of those findings on the relationship between PTG and HRQOL in cancer survivors.Multiple electronic databases were systematically searched using the concepts 'posttraumatic growth', 'cancer', and 'health-related quality of life'. Eligible studies (published until 2018) were reviewed, quality-assessed, and effect sizes were extracted and synthesized.Of the 37 included articles, 22 received a rating of 'weak', 11 'moderate' and 4 'strong' in study quality assessment. The overall sample comprised 7954 individuals, mean age of 55.30 years, >50% females, predominantly breast cancer, and survivors mainly within 5 years post-diagnosis. The synthesized results revealed a positive association between PTG and HRQOL (Fisher's z= 0.16) on a total scale, with significant high heterogeneity (I2=75%). Variations in HRQOL measurement and methodological inconsistency contributed to study-level differences of effect sizes. Sample-level characteristics such as geographic region, smaller sample sizes (n < 100) and so on contributed to heterogeneity.Studies assessing the relationship between PTG and HRQOL were heterogeneous, of weak study quality generally, and results were difficult to combine.Most studies found a positive relationship between the factors suggesting that PTG may play a role for successful coping following cancer. However, studies of higher quality and longitudinal design are needed.
000157224 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000157224 588__ $$aDataset connected to CrossRef, PubMed,
000157224 7001_ $$0P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDoege, Daniela$$b1$$udkfz
000157224 7001_ $$0P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aThong, Melissa S Y$$b2$$udkfz
000157224 7001_ $$0P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aArndt, Volker$$b3$$eLast author$$udkfz
000157224 773__ $$0PERI:(DE-600)1500487-9$$a10.1016/j.jad.2020.07.044$$gVol. 276, p. 159 - 168$$p159 - 168$$tJournal of affective disorders$$v276$$x0165-0327$$y2020
000157224 909CO $$ooai:inrepo02.dkfz.de:157224$$pVDB
000157224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)820d29ab03f702f61c6c92df377d2846$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000157224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)55389e9f54d8411e6e6eddcec489bb1b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000157224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24fe6057396bec79d2638615b12eb989$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000157224 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000157224 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000157224 9141_ $$y2020
000157224 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-01-06$$wger
000157224 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ AFFECT DISORDERS : 2018$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-06
000157224 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-06
000157224 9202_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000157224 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000157224 9200_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000157224 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000157224 9201_ $$0I:(DE-He78)C071-20160331$$kC071$$lC071 Cancer Survivorship$$x0
000157224 980__ $$ajournal
000157224 980__ $$aVDB
000157224 980__ $$aI:(DE-He78)C071-20160331
000157224 980__ $$aUNRESTRICTED